Ritu Aneja, PhD
Professor of Cancer Biology
Distinguished University Professor
Director, Graduate Studies in Biology
Director, The MBD (Molecular Basis of Disease) Program
Georgia State University
Atlanta, GA, USA
Dr. Aneja is Distinguished University Professor, Professor of Cancer Biology, Director of Graduate Studies in Biology, and Director of the Molecular Basis of Disease Program at Georgia State University in Atlanta, GA, where she was recently awarded the Outstanding Senior Faculty Award. She is also the co-founder of ICART (International Consortium for Advancing Research on Triple Negative Breast Cancer), a consortium of research groups from 11 countries whose collective mission is to bring together complementary expertise and resources from across the globe to pursue joint research projects, advance knowledge on triple-negative breast cancer and reduce global breast cancer-related disparity. She holds several patents and is also co-founder of Novazoi Theranostics, Inc., a company dedicated to cancer biomarker and nutraceutical research. She has published over 100 peer-reviewed research articles and presented over 40 invited talks, including a recent TED-style talk as part of the 2016-2017 “Women Inspire” series, a prestigious initiative from Georgia State University’s Office of the Provost. Her lab is actively engaged in interdisciplinary research on novel tumor biomarkers, cancer-related health disparities, and identification of non-toxic anti-cancer compounds from natural sources. She regularly serves as a Scientific Reviewer for the NCI and DoD as well as other research organizations in Europe, Canada, Israel, and China.